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The COVID-19 pandemic is undoubtedly the greatest challenge in peacetime facing the world for 
more than 100 years. No country is untouched with more than 100 million confirmed cases and over 
two million deaths as of 28 January 2021 (1), and the actual number of infections is probably closer 
to one billion as few countries had sufficient testing capacity to identify all cases, particularly 
throughout early 2020. 
 
The effectiveness of national responses to the pandemic has been very unequal. Whereas some 
countries, particularly in East and Southeast Asia and Oceania, have been able to bring the epidemic 
provisionally under control though with continuing outbreaks, much of the rest of the world is still 
struggling with expanding epidemics and an escalating death toll. In addition to the physical and 
mental health impact and disruptions to health services, it is likely that the social and economic 
devastation will be with us for the years to come. The sobering reality is that we are only at the end 
of the beginning, not the beginning of the end. 
 
While dealing with the acute stage of the pandemic, we need to start planning for the long-term and 
shift our thinking to societies living with COVID-19, even if we should benefit from the protection of 
vaccines. The future trajectory of the pandemic will vary by country and depend on a combination of 
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at least five factors: societal and public health responses, vaccine coverage, the duration of natural 
and vaccine-induced immunity, seasonality, and future mutations of the virus (2,3). 
 
The recent emergence of new variants of SARS-CoV-2 is at the same time expected since RNA viruses 
mutate and the number of people infected in the world is enormous, and a major concern since this 
is probably only the beginning and evolutionary pressure from vaccination, particularly incomplete 
vaccination, may provide a breeding ground for escape mutants. It seems that at least the B.1.1.7 
British variant is inactivated by the current vaccines and both Novavax and Janssen reported 
protection against the South African 501Y.V2 variant. However, other, more divergent and complex 
mutations may render vaccines less effective.  It may also mean that vaccines have to be redesigned 
regularly, that multivalent vaccines may need to be developed, and that, just as for influenza, 
countries may need to periodically vaccinate - all this at a high cost. 
 
The silver lining is that unprecedented scientific collaboration has achieved in months what would 
normally take decades with several safe and effective vaccines on the market, as well as diagnostics 
and, to a lesser degree, therapeutics. But scientific innovation alone is insufficient. Sustained 
progress in bringing the virus under control requires continued compliance with all non-
pharmaceutical measures alongside the global rollout of equitable and efficient vaccination 
programmes and vaccine uptake. 
 
With our increasing understanding of the virus and our new armamentarium of tools against it, the 
likely scenario is that most countries will gradually begin to control SARS-CoV-2 with very low 
mortality but with occasional flare-ups, possibly seasonal outbreaks because of waning immunity or 
the emergence of new variants of concern.  
3 
 
However, the crisis is not over anywhere until it is over everywhere. Some countries are not yet 
sufficiently protected and widespread testing and contact tracing, including for international travel, 
will be essential. We must also ensure that everyone, everywhere has equitable access to safe and 
effective vaccines starting with the most vulnerable, including in low and middle income countries. 
This is not only a moral imperative, but as long as one country in the world is affected by COVID-19, 
no country is safe. Equitable access to COVID-19 vaccines is becoming one of the most pressing 
geopolitical issues of our time. 
 
As we rapidly roll-out vaccination programmes to save lives and livelihoods, we must also address 
the long-term health and socio-economic challenges ahead of us. But there is also an opportunity to 
make our societies and systems more resilient and just, by accelerating much need changes in many 
areas such as health, education, workplace policies, urban planning, food production, and 
environmental policy. 
 
Although it is unlikely that we can eradicate SARS-CoV-2 in the foreseeable future, we have the tools 
and strategies to prevent COVID-19 outbreaks from spiralling into major epidemics while protecting 
those most at risk of developing severe disease. As we have seen in many settings, hard-won gains 
are easily reversed and there will always be a risk of resurgence. Success hinges on action at all levels 
– to protect ourselves we must protect our communities. 
 
We must also learn critical lessons to better prepare for the next epidemic, and important efforts are 
under way in this regard (4). It may well be that we are entering an age of pandemics due to our 
increasing inability to live in harmony with natural ecosystems in our interconnected world (5). 
Indeed, infectious diseases are emerging at an accelerating rate and more than 60% of those 
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emerging in humans are zoonoses, most of which originate in wildlife (72%) (6). The risk is further 
compounded by the profound health impacts of the global climate crisis (7). 
 
International collaboration is vital for epidemic preparedness and response as “public health goes 
global” (8). In addition to the global leadership of the World Health Organisation, regional bodies are 
playing an increasingly important role in providing political leadership and strengthening resilience 
and preparedness tailored to unique national contexts, from the African Union to the European 
Union and the Association of Southeast Asian Nations. Regional entities should also rapidly embrace 
much needed cross-sectoral strategies, beyond the health sector. China’s support through COVAX 
and bilateral supply of vaccines should play a major part in ensuring equitable access. 
 
Now more than ever we must break the vicious cycle of panic and neglect associated with 
pandemics and sustainably invest in prevention and preparedness (9). As COVID-19 has amply 
demonstrated, epidemics can trigger major economic and security crises, and effectively managing 
them therefore requires a whole-of-society approach, underpinned by robust and well-resourced 
public health systems. We must also work to overcome the silos between human, animal, and 
environmental health, investing in systems that embrace the critical intersection between these 
fields as advocated by the One Health approach (10). The COVID-19 pandemic is a profound tragedy 
and we must act now to ensure we are better prepared when the next epidemic inevitably strikes. 
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